The Clinical Significance of Metabolic Adipo-myokines and Alterations of Body Composition in Patients With End Stage Lung Cancer
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Number of white blood cell change among before, during and after cancer therapy
研究概览
简要总结
The investigators conduct this prospective study and wish to elucidate the association of serial change of body composition, serum adipo-myokines and adverse effect of chemotherapy and lung cancer prognosis
详细描述
Recently, the skeletal muscle was viewed as having biochemical function in additional to traditional biomechanical function. What's more important is that muscles could synthesize and release adipo-myokines during contraction. The adipo-myokines can affect muscle regeneration, muscle atrophy, muscle mass, autophagy, fatty acid oxidation and mitochondrial biosynthesis.Studies have also found that exercise can promote the function of macrophages and regulate both pro-inflammatory and anti-inflammatory phenotypes, helping the body to establish a stable immune balance.
Since body composition can illustrate malnutrition status and cancer cachexia present, and body composition can be affected by serum adipo-myokines level. Therefore, the investigators conduct this study and wish to see the association of serial body composition and serum adipo-myokines changes with lung cancer clinical outcomes and adverse effect of any anti-cancer regimen.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of lung cancer stage III to stage IV
- •Adults over 20 years old
- •Daily performance status of 0- 2
排除标准
- •Cardiac stents or pacemakers
结局指标
主要结局
Number of white blood cell change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of white blood cell count among week 0, week 4 and week 12
Percentage of body fat change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of percentage of body fat among week 0, week 4 and week 12
Percentage of total body water change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of total body water percentage among week 0, week 4 and week 12
Percentage of soft lean mass change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of soft lean mass percentage among week 0, week 4 and week 12
Concentration of plasma CEA change among before, during and after cancer therapy
时间窗: week 0, week 4 and week 12 after cancer theraphy
assessing the change of plasma CEA concentration among week 0, week 4 and week 12
Concentration of plasma albumin change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma albumin concentration among week 0, week 4 and week 12
Concentration of plasma myostatin change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma myostatin concentration among week 0, week 4 and week 12
Concentration of plasma FSTL-1 change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma FSTL-1 concentration among week 0, week 4 and week 12
Concentration of plasma IL-6 change among before, during and aftercancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma IL-6 concentration among week 0, week 4 and week 12
Concentration of plasma irisin change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma irisin concentration among week 0, week 4 and week 12
Concentration of plasma adiponectin change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma adiponectin concentration among week 0, week 4 and week 12
Concentration of plasma MCP-1 change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma MCP-1 concentration among week 0, week 4 and week 12
Concentration of plasma aquaporin change among before, during and after cancer therapy
时间窗: week 0 , week 4 and week 12 after cancer theraphy
assessing the change of plasma aquaporin concentration among week 0, week 4 and week 12
次要结局
未报告次要终点